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&DNA Recognition
Metal-Ion-Regulated Miniature DNA-Binding Proteins Based on
GCN4 and Non-native Regulation Sites
Emmanuel Oheix and Anna F. A. Peacock*[a]
Abstract: The design of artificial peptide dimers containing
polypyridine switching domains, for which metal-ion coordi-
nation is shown to regulate DNA binding, is reported. Short
peptides, based on the basic domain of the GCN4 transcrip-
tion factor (GCN4bd), dimerised with either 2,2’-bipyridine
(bipy(GCN4bd)2) or 2,2’:6’,2’’-terpyridine (terpy(GCN4bd)2)
linker units, undergo a conformational rearrangement on
CuII and ZnII coordination. Depending on the linker substitu-
tion pattern, this is proposed to alter the relative alignment
of the two peptide moieties, and in turn regulate DNA bind-
ing. Circular dichroism and UV–visible spectroscopy reveal
that CuII and ZnII coordination promotes binding to DNA
containing the CRE target site, but to a differing and oppo-
site degree for the two linkers, and that the metal-ion affini-
ty for terpy(GCN4bd)2 is enhanced in the presence of CRE
DNA. Binding to DNA containing the shorter AP1 target site,
which lacks a single nucleobase pair compared to CRE, as
well as half-CRE, which contains only half of the CRE target
site, was also investigated. CuII and ZnII coordination to
terpy(GCN4bd)2 promotes binding to AP1 DNA, and to
a lesser extent half-CRE DNA. Whereas, bipy(GCN4bd)2, for
which interpeptide distances are largely independent of
metal-ion coordination and less suitable for binding to these
shorter sites, displays allosteric ineffective behaviour in these
cases. These findings for the first time demonstrate that bio-
molecular recognition, and specifically sequence-selective
DNA binding, can be controlled by metal-ion coordination
to designed switching units, non-native regulation sites, in
artificial biomolecules. We believe that in the future these
could find a wide range of applications in biotechnology.
Introduction
In nature, allosteric regulation involves the binding of an effec-
tor molecule to the regulation site in a protein or enzyme,
which is distinct from the active site. This binding event can
trigger a conformational change, which modifies the activity of
the global system. The ability to identify the regulation mecha-
nism provides an opportunity to control protein or enzyme ac-
tivity. Alternatively, a non-native regulation site can be synthet-
ically incorporated into proteins, in an effort to artificially con-
trol their activation, and represents an interesting challenge for
chemists and biochemists.[1]
Transcription factors are activated and regulated through
various allosteric mechanisms.[2] Notable examples which are
relevant to this work are metal-sensing transcriptional regula-
tors which trigger expression of the machinery required for
heavy metal detoxification or regulation, in response to accu-
mulation of specific metal ions. For example, SmtB and ArsR
are bound to gene promoter sites in the absence of ZnII and
AsIII, respectively, but a conformational change is triggered on
metal-ion coordination resulting in dissociation from DNA and
expression of metallothioneins.[3] In contrast, MerR is bound to
DNA in both the absence and presence of HgII, but HgII bind-
ing induces a conformation change which triggers DNA un-
winding and subsequent transcription of the mer operon, re-
sponsible for HgII detoxification.[4]
GCN4 is a yeast transcription factor involved in amino acid
regulation, stimulating the transcription of more than 30
amino acid biosynthetic genes. Miniature artificial proteins con-
sisting of the basic leucine zipper (b-ZIP) domain (ca. 60 out of
the 281 native residues) of GCN4 have been reported to retain
similar DNA affinity and selectivity to the native protein.[5] The
basic (DNA binding) domain makes specific contact with the
target sequence, through electrostatic and hydrogen bonding
interactions to the phosphate backbone and exposed nucleo-
bases in the major groove. Notably this domain is only folded
into an a-helix when bound to the target site.[6] The leucine
zipper domain is responsible for dimerisation of the peptide,
which is important for strong DNA binding.[7]
One strategy adopted by chemists to control GCN4 DNA
binding, is to perturb folding of the leucine zipper domain by
incorporation of non-natural residues bearing photoswitcha-
ble[8] or metal-chelating ligands[9] as side-chains. Some of these
stimuli-responsive leucine zipper mimics have subsequently
been shown to regulate AP1 transcription activity in vivo, at-
tributed to an inhibition of b-ZIP peptide dimerisation.[10] Alter-
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natively Kim and co-workers prepared a synthetic peptide
dimer, in which the entire leucine zipper domain was replaced
by a disulfide bond between two cysteine (Cys) residues. This
first artificially dimerised miniature GCN4 basic domain peptide
was reported to retain similar DNA binding ability to the
native protein.[11] A number of different linkers have subse-
quently been investigated.[12,13] Of particular relevance to this
work are the reports by Schepartz and co-workers on a bis(ter-
pyridyl)iron(II) complex as the dimerisation domain, where the
two terpyridyl ligands are substituted on the central pyridine
ring with a basic domain peptide, and a non-metallated bipyr-
idyl peptide dimer.[14] Importantly they were able to establish
a relationship between the distance separating the two pep-
tide basic domains and target DNA affinity.[14] This was further
exploited by MascareÇas and co-workers, who developed the
only system with a switchable linker, a photoswitchable azo-
benzene group.[15] The trans azobenzene linker could be con-
verted to the cisoid form upon light irradiation at 365 nm, thus
shortening the distance between the two basic domains and
enhancing DNA binding. However, the switch is not fully rever-
sible as the azobenzene cisoid-to-transoid reconversion over
time is prevented when bound to target DNA.
Though the conformational rearrangement of chelating li-
gands on metal-ion coordination to promote DNA binding of
small synthetic molecule ligands has been reported,[16,17] to the
best of our knowledge no reports exist of their introduction
into larger biomolecules for controlling DNA binding. Here we
investigate the potential of utilising non-native polypyridine
linkers as an allosteric regulation site, by exploiting their trans-
oid-to-cisoid conformational rearrangement upon metal-ion
complexation. Quantum mechanical calculations in the gas-
phase estimate the enthalpy of the cisoid-conformation of 2,2’-
bipyridine (bipy) and 2,2’:6’,2“-terpyridine (terpy) to be 26.5
and 52.5 kJmol1 higher than their respective transoid confor-
mations, principally due to steric repulsion between two cen-
tral hydrogen atoms.[18, 19] However, the cisoid conformation is
favoured upon metal-ion complexation, due to the formation
of highly stable 5-membered chelate rings. Rebek and co-
workers first took advantage of the reorientation of 2,2’-bipyri-
dine substituents on metal-ion complexation, to introduce an
allosteric regulation site into a crown ether, thus regulating its
alkali-metal-ion binding capacity.[20] The metal switching behav-
iour of substituted bipyridine and terpyridine has subsequently
found many applications, primarily in aprotic solvents,[20–23] and
has been introduced into a range of macromolecular synthetic
(e.g. , polymers)[24] and biological structures (e.g. , DNA).[25] De-
spite the latter there are no reports of their introduction into
peptides and their subsequent switching behaviour, beyond
the work by Kelly and co-workers who introduced a bipyridine
unit into a peptide backbone and reported that CuII coordina-
tion triggers a transoid-to-cisoid conformational change, but
only under basic conditions (pH 9.5).[26] We recently reported
on the development of model switching units consisting of
either a disubstituted bipyridine or terpyridine unit as the di-
merisation domain for peptides through the thiol side-chain of
Cys, and investigated their CuII and ZnII coordination chemis-
try.[27] The bipyridine linker was designed such that the result-
ing transoid-to-cisoid conformational transition on metal-ion
coordination would not alter the distances between the pep-
tide units, and was proposed to be allosteric ineffective. In
contrast the terpyridine linker was designed so that the dis-
tance between the two peptides would be highly sensitive to
metal-ion coordination.
Here we extend this work to larger protein fragments capa-
ble of biomolecular recognition. We propose to test the applic-
ability of our metal-ion regulation sites as artificial dimerisation
units for GCN4, which represents a well-studied system with
a plethora of mutagenesis and (minimal) sequence studies
identifying features important for selective DNA binding.[28–32]
This report therefore describes the synthesis and characterisa-
tion of miniature DNA binding proteins, based on the basic
domain of GCN4, dimerised by metal chelating bipyridine and
terpyridine units. The CuII and ZnII binding properties are evalu-
ated and how pyridine ring rotation and subsequent reorienta-
tion of the peptide substituents, regulates DNA binding is re-
ported. Though this work focuses on GCN4, we propose that
this strategy, of dimerisation sites capable of regulating pep-
tide alignment, could be applied to a large number of biomo-
lecular recognition processes.
Results and Discussion
Design of a peptide allosteric regulation site
Our goal was to prepare a miniature DNA binding protein
which responds to the presence of metal ions (Figure 1). The
leucine zipper dimerisation domain of GCN4 was therefore re-
placed with a polypyridine linker (bipyridine or terpyridine) ca-
pable of binding to metal ions, such as CuII and ZnII. Our ap-
proach was to take advantage of the reactivity of the cysteine
(Cys) thiol side-chain to couple di(bromomethyl) derivatives
of bipyridine and terpyridine, through a nucleophilic substitu-
tion reaction. The two metal chelating linker units selected,
5,5’-dibromomethyl-2,2’-bipyridine and 6,6’’-dibromomethyl-
2,2’:6’,2’’-terpyridine, were synthesised as reported previous-
ly,[14c, 27] and subsequently reacted with the single Cys amino
acid introduced for this purpose towards the C terminus of
peptide sequences based on GCN4.
The substitution of bipyridine along the axis of the pyri-
dinepyridine bond (5,5’-position) should place the peptide
substituents about 10  apart, independent of whether the bi-
pyridine adopts the cisoid[33] or transoid conformation.[34]
Though the bipyridine cisoid-to-transoid conformational transi-
tion would result in reorientation of substituents, the free rota-
tion of the thioether motif should be able to compensate for
this. In contrast, placement of substituents at the 6,6’’-position
of terpyridine would result in substituents located either about
5 (cisoid)[22] or 12  (transoid)[35] apart (Figure 2). These linkers
therefore represent the two extremes, where intersubstituent
distance is independent (allosteric ineffective) or highly depen-
dent (allosteric effective) on the polypyridine linker conforma-
tion. Such comparison should allow for important relationships
between intersubstituent distance and the regulation process,
to be established.
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DNA binding peptide sequence design
It has previously been demonstrated that the leucine zipper
domain of GCN4 can be replaced by a chemical linker and still
retain similar DNA binding.[11–15] For example, a study by Kim
and co-workers, compared a library of peptide dimers (of dif-
ferent lengths) derived from the basic domain of the GCN4
transcription factor. These peptides all bore a GGC motif
toward the C terminus to allow dimerisation through thiol oxi-
dation. Both DNase I footprinting and circular dichroism (CD)
melting experiments revealed that the 15 amino acid sequence
KRARNTEAARRSRAR contains the necessary conserved residues
required for the formation of specific contacts with the DNA
target site CRE, whereas binding to AP1 required additional
conserved residues.[13] The linker region LQRMKQL, separating
the basic and leucine zipper domains and which allows for the
formation of an uninterrupted a-helix,[36] has been reported to
be important for thermal stability on binding to both CRE and
AP1 DNA.[11,13]
Based on this literature our initial design, Ac-ALKRARN-
TEAARRSRARKLQRMKQLGGCG-NH2, included both the basic
domain and the flexible linker region so as to achieve strong
and selective DNA binding. However, DNA binding was found
to be sufficiently strong so that both the bipyridine and terpyr-
idine peptide dimers bound to DNA in the absence of any
metal ions (confirmed by gel electrophoresis), and the addition
of CuII or ZnII did not alter DNA binding.[37] This lack of DNA
binding regulation in response to the presence of CuII and ZnII
ions is most likely due to the peptide sequence adopted,
which contains both a flexible linker domain and Gly residues
which precede the Cys. This flexible section may be able to
buffer conformational changes arising from the allosteric site,
thus reducing its ability to influence DNA binding. Therefore,
the peptide sequence adopted for this work, GCN4bd Ac-AL-
KRARNTEAARRSRARCG-NH2, contains 17 conserved GCN4 resi-
dues (corresponding to the domain located between residue
229 and 245 of GCN4) which is predominantly the basic
domain and which lacks the flexible linker domain (thought to
be important in the stability of the DNA complex). The location
of Cys (equivalent to Lys246 of native GCN4) is such that the
two thiols from the side-chains should be positioned about
7.1  apart in the complex formed between GCN4 and DNA
containing the CRE target site, most suitable for either a 5,5’-
dimethyl-2,2’-bipyridine (cisoid and transoid) or for the cisoid
form of 6,6’’-dimethyl-2,2’:6’,2’’-terpyridine (measurements
based on crystal structure PDB code 2DGC; Figure 3).[38] In the
similar complex formed between GCN4 and DNA containing
the related AP1 target site, which lacks one nucleobase pair
compared to CRE, these are positioned closer together at
about 5.7  apart (Figure 3), a more suitable distance for only
the cisoid form of the 6,6’’-dimethyl-2,2’:6’,2’’-terpyridine linker
unit (measurements based on crystal structure PDB code
1YSA).[39] This minimal peptide sequence, GCN4bd, has been
designed such that the alignment of folded a-helices, the DNA
binding domain, will be highly dependent on the conforma-
tion of the linker unit. This peptide was synthesised, purified
and characterised by routine methods.[40]
Preparation of GCN4 peptide dimers containing allosteric
regulation sites
The linkers, 5,5’-dibromomethyl-2,2’-bipyridine and 6,6’’-dibro-
momethyl-2,2’:6’,2’’-terpyridine, were successfully coupled to
Figure 2. Scheme illustrating the impact of the cisoid–transoid conformation-
al transition on the intersubstituent distance for the 5,5’-disubstituted 2,2’-
bipyridine, and 6,6’’-disubstituted 2,2’;6’,2“-terpyridine linker.
Figure 1. Cartoon illustration of the designed metal-ion-dependent DNA
binding of: A) the bipyridine, and B) terpyridine dimerised GCN4 DNA bind-
ing domains. A conformational change, achieved on metal-ion coordination,
is most important for terpyridine binding to DNA.
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the Cys side-chain to generate GCN4 peptide dimers (bipy-
(GCN4bd)2 and terpy(GCN4bd)2) which contain a metal-ion
chelation site in place of the leucine zipper dimerisation
domain. Though 5,5’-disubstituted-2,2’-bipyridine compounds
have previously been introduced into peptides,[14c,26,41,42] this
and our recently reported model compounds with gluta-
thione[27] constitute, to the best of our knowledge, the first de-
scribing the insertion of a disubstituted terpyridine unit as
a linker between two peptide strands.
A control peptide dimer, which lacks a metal chelating unit
(bipyridine or terpyridine), was prepared by dimerising two
equivalents of GCN4bd by formation of a disulfide bond to
generate (GCN4bd)2.
All peptide dimers were purified by reversed phase C18-
HPLC and characterised by ESI-MS (Figures S1–S6 in the Sup-
porting Information).
Circular dichroism: folding of GCN4 peptide dimers in the
presence of DNA
Peptides containing basic amino acids can non-specifically
bind in the presence of the negatively charged DNA phos-
phate backbone.[43] However, peptides derived from the basic
domain of GCN4 have been shown to display sequence-specif-
ic folding into a-helices in the presence of DNA containing
a GCN4 target site (such as CRE).[13] Therefore, CD, and specifi-
cally the ellipticity at 208 and 222 nm, can be used to infer
DNA binding. This is particularly important as we were unable
to obtain band retardation for any of the GCN4bd peptide
dimer DNA complexes in gel electrophoresis band-shift assays
in either the absence or presence of metal ions, even at CD rel-
evant concentrations. Whereas bipyridine dimers of the longer
peptides, vide supra, did display band retardation when bound
with target CRE DNA.[37] This is consistent with a shorter pep-
tide design and previous reports indicating that truncation of
the hinge area of GCN4, results in a decrease in the stability of
the peptide–DNA complex, preventing successful separation
under electrophoresis conditions.[11,12a, 13]
The CD spectrum of a 5 mm solution of (GCN4bd)2, lacking
the chelating polypyridyl dimerisation unit, in 10 mm phos-
phate buffer pH 7.4 is consistent with a random coil structure.
On addition of 1 equivalent of non-specific (NS) DNA, there
was a small increase in the negative signal (V222 3.4103!
5.6103 degdmol1 cm2 per residue). In contrast the addition
of 1 equivalent of target CRE DNA, resulted in a spectrum with
intense minima at 208 and 222 nm (V222 14.6
103 degdmol1 cm2 per residue), consistent with the formation
of an a-helix and binding to the DNA (Figure 4A).
Similar results were obtained for the analogous experiments
performed with the dimers containing the polypyridyl linker
domains, bipy(GCN4bd)2 and terpy(GCN4bd)2. The CD spectra
of 5 mm solutions of either bipy(GCN4bd)2 or terpy(GCN4bd)2
in 10 mm phosphate buffer pH 7.4 are also consistent with
random coil structures, which are largely unchanged in the
presence of 1 equivalent of NS DNA (Figure 4B and C). Addi-
tion of 1 equivalent of target CRE DNA to a 5 mm solution of
bipy(GCN4bd)2 yields a CD spectrum with the characteristic a-
helix minima at 208 and 222 nm (V222 13.1
103 degdmol1 cm2 per residue; Figure 4B). This is comparable
to that obtained for (GCN4bd)2 confirming that DNA binding
can be retained on replacing a disulfide bond with a bipyridine
unit.[14c] In contrast, the addition of 1 equivalent of target CRE
DNA to a 5 mm solution of terpy(GCN4bd)2 yields a CD spec-
trum with minima at 204 and 222 nm (V222 9.9
103 degdmol1 cm2 per residue; Figure 4C). Though this is con-
sistent with a more folded peptide domain, this is notably less
a-helical than either the disulfide or bipyridine dimerised pep-
tide analogues, which suggests reduced binding to CRE DNA.
The bipy(GCN4bd)2 peptide domains fold in the presence of
CRE DNA, consistent with our design that both the cisoid and
transoid bipyridine conformation would be capable of binding
to CRE DNA. However, the terpy(GCN4bd)2 peptide dimer is
less well folded in the presence of CRE DNA, suggesting that
the distance between the peptides is less appropriate for the
peptide alignment required for binding to the CRE target site.
This is most likely due to the terpyridine dimerisation unit not
fully adopting a conformation which is optimal for binding to
CRE DNA, which could be consistent with either the transoid
(Figure 2) or a mixed cisoid–transoid conformation. These re-
sults were obtained in the absence of metal ions, and so it
therefore remained for us to evaluate if this folding is sensitive
to the presence of metal ions, such as CuII and ZnII, and specifi-
cally whether these can be exploited to regulate DNA binding.
Figure 3. Cartoon illustrating the distances between sulfur atoms from a the-
oretical Cys, introduced as the best aligned rotamer, in place of residue
Lys246 of the GCN4 homodimer, when complexed with duplex DNA contain-
ing the: A) CRE (based on PDB ID 2DGC[38]), or B) AP1 (based on PDB ID
1YSA[39]) target site, which differ in a single nucleobase pair. The DNA bases
are indicated with single letters.
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Circular dichroism: influence of metal ions on DNA binding
CD spectra recorded of all three peptide dimers, (GCN4bd)2,
bipy(GCN4bd)2 and terpy(GCN4bd)2, display poor a-helicity in
the absence of DNA or in the presence of NS DNA. The addi-
tion of two equivalents of either CuCl2 or ZnCl2 resulted in
only minor changes (Figure S7 in the Supporting Information).
However, in the presence of DNA containing the CRE target
site, the three peptides display a notable increase of the nega-
tive ellipticity at 222 nm, suggesting partial or full folding into
a-helices. The addition of two equivalents of either CuCl2 or
ZnCl2 to a 5 mm solution of (GCN4bd)2 in the presence of CRE
DNA, does not result in any further change in the CD spec-
trum, consistent with a design which lacks a metal-ion-chelat-
ing polypyridine linker unit (Figure 5A). However, the helicity
of bipy(GCN4bd)2 in the presence of CRE DNA, increases by
29% upon addition of two equivalents of CuCl2 (V222 13.1
103!17.0103 degdmol1 cm2 per residue) and 70% upon
addition of two equivalents of ZnCl2 (V222 13.1103!
22.3103 degdmol1 cm2 per residue; Figure 5B). In contrast,
the peptide helicity of terpy(GCN4bd)2 in the presence of CRE
DNA doubles upon addition of two equivalents of CuCl2 (V222
9.9103!20.0103 degdmol1 cm2 per residue), but only
increases by a more modest 55% upon addition of two equiv-
alents of ZnCl2 (V222 9.9103!15.4103 degdmol1 cm2
per residue; Figure 5C).
CD spectra indicate that both bipy(GCN4bd)2 and terpy-
(GCN4bd)2 experience an increase in the negative ellipticity at
222 nm upon metal-ion addition, which in turn is highly de-
pendent on the nature of the metal ion, that is, CuII versus ZnII.
The percentage change in molar ellipticity at 222 nm suggests
a higher affinity for DNA containing the CRE target site for Cu–
terpy(GCN4bd)2 and Zn–bipy(GCN4bd)2 complexes, and
a lower affinity for the Zn–terpy(GCN4bd)2 and Cu–bipy-
(GCN4bd)2 complexes (Figure 5). These changes are accompa-
nied by the appearance of a positive band at 268 nm in the
difference CD spectra, appearing upon addition of peptide
Figure 5. CD spectra of 5 mm solutions of CRE DNA and: A) (GCN4bd)2 oxi-
dised dimer, B) bipy(GCN4bd)2 and C) terpy(GCN4bd)2 in 10 mm phosphate
buffer pH 7.4, in the absence (g) and presence of 2 equivalents of either
CuCl2 (a) or ZnCl2 (c). Reversibility was monitored by addition of
10 equivalents of EDTA (c).
Figure 4. CD spectra of 5 mm solutions of: A) (GCN4bd)2 oxidised dimer,
B) bipy(GCN4bd)2, and C) terpy(GCN4bd)2 in 10 mm phosphate buffer
pH 7.4, in the absence (g) of duplex DNA, and in the presence of 5 mm NS
(a) or CRE DNA (c).
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conjugates to CRE DNA and growing in intensity upon metal-
ion addition. This can be assigned to the bending of the DNA
which has previously been reported to occur upon binding of
basic zipper peptides.[6, 44]
These experiments indicate that binding to DNA containing
the CRE target site is sensitive to the presence of metal ions,
when the linker domain contains a chelating ligand. The en-
hancement in DNA binding for terpy(GCN4bd)2 on coordina-
tion of metal ions is consistent with the terpyridine adopting
the cisoid conformation, which we propose is more appropri-
ate for DNA binding. However, we also observe an enhance-
ment, though to a lesser extent, for the bipyridine linker and
therefore not only the transoid–cisoid conformational change,
but other factors, such as enhanced electrostatic attraction
with the DNA, may also contribute.
Circular dichroism: reversible DNA binding
In order to assess reversibility, EDTA was added to solutions of
the metal–peptide conjugates in the absence and presence of
DNA. Addition of excess EDTA (10 equivalents per metal ion)
resulted in no significant change to the CD spectra recorded in
either the absence or presence of NS DNA (Figure S7 in the
Supporting Information). However, a decrease in the negative
ellipticity at 222 nm was observed for both bipy(GCN4bd)2 (Cu
V222 17.0103!11.0103; Zn V222 22.3103!11.0
103 degdmol1 cm2 per residue) and terpy(GCN4bd)2 (Cu V222
20.0103!9.5103; Zn V222 15.4103!8.0
103degdmol1 cm2 per residue) in the presence of CRE DNA
(Figure 5B and C). The resulting spectra are similar to those re-
corded prior to metal-ion complexation, which is importantly
consistent with a fully reversible process. In contrast, no
change was observed in the spectrum of (GCN4bd)2 after addi-
tion of EDTA, consistent with the oxidised dimer not coordinat-
ing a metal ion in the linker domain.
UV–visible CuII and ZnII titrations
It remained necessary to evaluate the CuII and ZnII coordination
chemistry of the two new peptide dimers, bipy(GCN4bd)2 and
terpy(GCN4bd)2. The UV–visible spectrum of a solution of
bipy(GCN4bd)2 in 20 mm phosphate buffer pH 7.4 displays
two transitions with lmax at 299 and 246 nm, assigned as p!
p*1 and p!p*2 transitions, respectively (Figure 6).[45] The anal-
ogous spectrum of terpy(GCN4bd)2 shows a peak with lmax
298 nm attributed to p!p*1, however, the p!p*2 transition
overlaps with that for the peptide bond (Figure 6). These spec-
tra are consistent with a predominantly transoid conformation
for both the bipyridine and terpyridine linker unit.[27,46,47]
The bands shift to lower energy upon ZnII and CuII complex-
ation, allowing estimation of an apparent binding constant.[41]
Aliquots of a stock solution of ZnCl2 were titrated into a 5 mm
solution of bipy(GCN4bd)2 or terpy(GCN4bd)2 in 20 mm phos-
phate buffer pH 7.4, up to 3 equivalent of ZnCl2. This resulted
in the steady decrease in the absorbance at 299 (bipy-
(GCN4bd)2) and 298 nm (terpy(GCN4bd)2), and an increase in
the absorbance at 313 and 320 nm (bipy(GCN4bd)2), and 328
and 341 nm (terpy(GCN4bd)2 ; Figure 6). Continuous-variation
plots are consistent with predominant formation of a 1:1 com-
plex between ZnII and either bipy(GCN4bd)2 or terpy-
(GCN4bd)2 under these conditions (Figure S8 in the Supporting
Information). The isosbestic points at 308 (bipy(GCN4bd)2) and
318 nm (terpy(GCN4bd)2) are consistent with the clean conver-
sion to a metal bound complex. A plot of the absorbance of
the new transitions versus ZnII concentration was fitted to
a 1:1 binding equation (Figure 6), and the extinction coeffi-
Figure 6. UV–visible spectra for the metal titration of peptide conjugates. ZnCl2 (A and B) or CuCl2 (C and D) were added to solutions containing 5(0.6) mm
of either bipy(GCN4bd)2 (A and C) or terpy(GCN4bd)2 (B and D) in 20 mm phosphate buffer pH 7.4. c : 0 equivalent metal added; c : 1 equivalent CuCl2
added; c : 1 equivalent ZnCl2 added; a or a : between 0 and 1 equivalent of CuCl2 or ZnCl2 added; d or d : more than 1 equivalent added.
C) Buffer concentration was 100 mm phosphate and 20 mm glycine was added as competitor. E) Plot of absorbance (monitored at 320 (&), 328 nm (&) for
bipy(GCN4bd)2 and 341 (*), 348 nm (*) for terpy(GCN4bd)2) versus the equivalence of metal ion (with ZnCl2 (c) and CuCl2 (c)). Line represents best fit
for a 1:1 metal/peptide dimer conjugate binding ratio.
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cients of the peptide dimers and the resulting ZnII complexes
determined and reported in Table 1. Taking into account the
competitive metal-ion binding of the phosphate buffer em-
ployed in these experiments,[48] binding constants, logKm, were
calculated to be 6.920.03 for formation of the Zn–bipy-
(GCN4bd)2 complex and 5.670.03 for the analogous Zn–
terpy(GCN4bd)2 complex.
The addition of increasing aliquots of CuCl2 into a 5 mm solu-
tion of bipy(GCN4bd)2 or terpy(GCN4bd)2 in 20 mm phos-
phate buffer pH 7.4, resulted in a similar decrease in the ab-
sorbance at 299 nm (bipy(GCN4bd)2) and 298 nm (terpy-
(GCN4bd)2), and an increase in the absorbance at 317 and
328 nm (bipy(GCN4bd)2) and at 335 and 348 nm (terpy-
(GCN4bd)2). Again the isosbestic points at 309 (bipy-
(GCN4bd)2) and 320 nm (terpy(GCN4bd)2) are consistent with
clean formation of the complex, which has been identified as
a 1:1 complex by a continuous-variation plot (Figure S8 in the
Supporting Information). The plot of absorbance as a function
of increasing CuII concentration was fitted to a 1:1 binding
equation, from which extinction coefficients were determined
(Table 1). Titration of bipy(GCN4bd)2 with Cu
II had to be per-
formed in the presence of a competitor (20 mm glycine), in
order to accurately estimate the CuII affinity (Table 1). Forma-
tion constants, logKm, were determined to be 13.170.06 for
the Cu–bipy(GCN4bd)2 complex and 7.940.04 for the Cu–
terpy(GCN4bd)2 complex.
These results are consistent with the coordination of CuII
and ZnII to the polypyridyl chelating linker unit, which is associ-
ated with a transoid-to-cisoid conformational rearrangement.
Changes in the ligand p!p* bands is consistent with forma-
tion of a 1:1 complex and these data were fitted and binding
constants were extracted. However, due to the lower extinc-
tion coefficient for the metal-to-ligand charge transfer (MLCT)
and d–d transitions, we are unable to rule out the possibility
that formation of a 1:1 complex is followed by the formation
of a 1.5:1 or 2:1 complex as observed previously for related
small model compounds with glutathione (GS) in place of
GCN4bd (bipyGS2 and terpyGS2).
[27]
The results summarised in
Table 1 are in good agreement
with previous reports for related
polypyridyl Cu/Zn coordina-
tion,[41,42] displaying a higher af-
finity for CuII than for ZnII. The
binding constants reported for
the Zn–bipy(GCN4bd)2 and Cu–
terpy(GCN4bd)2 complexes, are
similar to those we previously re-
ported for the analogous gluta-
thione dimers, bipyGS2 and ter-
pyGS2.
[27] However, the CuII affini-
ty of bipy(GCN4bd)2 is 10-times
greater than that for the analo-
gous bipyGS2, whereas the Zn
II
affinity of terpy(GCN4bd)2 is
three-times lower than that of
terpyGS2. These differences
highlight the non-innocent role of the peptide substituents,
where amino acid side-chains may be able to contribute to
and/or compete for metal-ion coordination. Intriguingly bind-
ing constants are largely unchanged for Zn–bipy(GCN4bd)2
and Cu–terpy(GCN4bd)2 which are the same species that dis-
play the best binding to CRE DNA, as indicated by CD. These
results could indicate that GCN4bd contributes to, or com-
petes for metal-ion coordination in Cu–bipy(GCN4bd)2 and
Zn–terpy(GCN4bd)2, making important amino acid side-chains
unavailable for, and thereby disrupting, DNA binding.
CuII and ZnII titrations in the presence of DNA
Similar CuCl2 and ZnCl2 titrations of bipy(GCN4bd)2 and terpy-
(GCN4bd)2 monitored by UV–visible and CD spectroscopy
were carried out in the presence of one equivalent of duplex
DNA (5 mm) containing either the CRE or NS site, so as to inves-
tigate metal binding to the polypyridine linkers under these
conditions, and to evaluate if metal binding to these linkers
and DNA binding of the peptide substituents is cooperative.
The UV–visible titrations all display a shift of the p!p* transi-
tion towards lower energies, consistent with CuII and ZnII bind-
ing to the polypyridyl linkers (Figures S9 (CRE DNA) and S10
(NS DNA) in the Supporting Information). Changes in absorb-
ance were plotted as a function of metal-ion concentration
(Figures S9E (CRE DNA) and S10E (NS DNA) in the Supporting
Information), the data were fitted to a 1:1 model and binding
constants were calculated, the results of which are reported in
Table 1. Considering a thermodynamic cycle linking the four
main species (peptide, peptide/metal, peptide/DNA and pep-
tide/metal/DNA) in equilibrium, any change in the metal-bind-
ing affinity of the peptide dimer conjugates is due to the DNA,
as DNA binding could alter the polypyridyl linkers conforma-
tion.[49,50] The affinity of terpy(GCN4bd)2 in the presence of NS
DNA is slightly greater for ZnII (logKm 6.160.03) and un-
changed for CuII (logKm 8.040.08) compared to the affinity
determined in the absence of DNA (ZnII, logKm 5.670.03; CuII,
logKm 7.940.04). However, the affinity for both CuII and ZnII is
Table 1. Summary of the UV–visible data obtained for CuII and ZnII coordination to polypyridyl peptide conju-
gates, bipy(GCN4bd)2 and terpy(GCN4bd)2, in the absence and presence of DNA (NS and CRE).
Peptide
conjugate
l
[nm]
eML
[m1 cm1]
Kapp
[m1]
Km
[m1]
R2
ZnCl2 bipy(GCN4bd)2 320 1.950.01 E+04 1.380.10 E+06 8.290.60 E+06 0.9986
terpy(GCN4bd)2 341 1.890.06 E+04 7.740.53 E+04 4.660.32 E+05 0.9989
ZnCl2 NS
DNA
bipy(GCN4bd)2 320
[a] 1.740.08 E+04 7.201.27 E+04 4.340.77 E+05 0.9939
terpy(GCN4bd)2 341 1.800.03 E+04 2.430.15 E+05 1.460.09 E+06 0.9987
ZnCl2 CRE
DNA
bipy(GCN4bd)2 320 1.900.02 E+04 1.290.32 E+06 7.771.95 E+06 0.9904
terpy(GCN4bd)2 341 1.620.02 E+04 6.940.57 E+05 4.180.34 E+06 0.9976
CuCl2 bipy(GCN4bd)2 328 1.550.01 E+04 2.940.39 E+06 1.480.20 E+13[b] 0.9966
terpy(GCN4bd)2 348 1.140.01 E+04 2.670.27 E+06 8.720.89 E+07 0.9972
CuCl2 NS
DNA
bipy(GCN4bd)2 328 1.540.01 E+04 7.340.57 E+05 9.250.72 E+11[c] 0.9979
terpy(GCN4bd)2 348 1.320.01 E+04 3.400.60 E+06 1.110.20 E+08 0.9941
CuCl2 CRE
DNA
bipy(GCN4bd)2 328 1.470.01 E+04 1.450.20 E+06 1.820.25 E+12[c] 0.9945
terpy(GCN4bd)2 348 1.350.07 E+04 4.800.88 E+06 2.570.47 E+09[d] 0.9950
[a] Absorbance at 320 nm corrected by subtracting the absorbance at 400 nm. Selected titrations performed in
the presence of: [b] 20, [c] 10, or [d] 0.2 mm glycine as competitor.
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considerably enhanced in the presence of DNA containing the
CRE target site (ZnII, logKm 6.620.04; CuII, logKm 9.410.07).
Therefore, the presence of the target DNA site increases the
metal-ion affinity of the terpyridine linker in a cooperative fash-
ion (Figure S11 in the Supporting Information). We propose
that terpy(GCN4bd)2 binds to DNA through the cisoid confor-
mation (Figure 1B), which is more preorganised for chelation,
resulting in enhanced metal-ion affinity. To the best of our
knowledge, this is the first example in which the presence of
a target DNA site promotes recruitment by an artificial switch-
ing device of its effector molecule.
In contrast, the ZnII affinity of bipy(GCN4b)2 decreases very
slightly in the presence of NS DNA (logKm 5.630.08), and re-
mains largely unchanged in the presence of DNA containing
the CRE target site (logKm 6.890.10). The CuII affinity of bipy-
(GCN4bd)2 decreases in the presence of DNA, regardless of the
presence of the target site (NS, logKm 11.970.03; CRE, logKm
12.260.06). Despite bipy(GCN4bd)2 binding to CRE DNA
being enhanced in the presence of metal ions (presumably
due to a combination of electrostatics and conformational
changes), binding to CRE DNA decreases the metal-ion affinity.
These results suggest that DNA binding does not necessarily
promote the more favourable cisoid conformation for metal-
ion chelation, consistent with a model in which both the cisoid
and transoid conformation are appropriate for DNA binding
(Figure 1A). Instead the DNA behaves like a competitive ligand
for the metal ions, either directly (metal binding to DNA), or in-
directly (peptide donor atoms which contribute to the metal-
ion coordination sphere are no longer available when bound
to DNA).
A CuII and ZnII metal-ion titration of bipy(GCN4bd)2/terpy-
(GCN4bd)2 in the presence of CRE DNA was also monitored by
CD spectroscopy (Figure S12 in the Supporting Information). A
plot of molar ellipticity at 222 nm, a measure of the a-helical
content and thereby DNA binding, as a function of metal-ion
equivalence is consistent with the formation of 1:1 complexes.
However, an exception could be the Cu–bipy(GCN4bd)2–CRE
system in which the smaller signal change is less conclusive
(Figure S12E in the Supporting Information).
Both peptide dimers display a higher affinity for CuII, and
peptide folding in the presence of CRE DNA, an indication of
DNA binding, is greatest for terpy(GCN4bd)2 when bound to
CuII. However, for bipy(GCN4bd)2 this is the case when bound
to ZnII, for which it has a lower affinity both in the absence
and presence of the CRE DNA target site. These differences are
likely due to coordination geometry preferences, where ZnII is
known to favour a tetrahedral[51,52] coordination geometry
whereas CuII tends to adopt a square planar[53] coordination
geometry, when bound to bipyridine. Although the terpyridine
transoid-to-cisoid conformation is required for binding to DNA,
and this is dependent on the affinity for the metal ion, which
is greatest for CuII, the bipyridine unit does not require this
conformational change. Rather greater DNA binding is likely to
be due to enhanced electrostatics on coordinating a metal ion.
Though the affinity of the bipyridine is greatest for CuII, the
forked alignment of GCN4 basic domains bound to DNA
(Figure 1) appears more suitable for a metal ion which adopts
a tetrahedral coordination geometry when bound to the bipyr-
idine dimerization domain.
Metal-ion affinity and the ability to regulate DNA binding
are therefore not mutually inclusive. A parallel can be drawn
with two natural transcription factors involved in metal-ion
regulation, Nmtr and SmtB, which belong to the same family,
but are capable of sensing different metal ions. This is ach-
ieved due to the metal-ion coordination geometry offered by
the allosteric site, and not the metal-ion affinity. Robinson and
co-workers report that, within a cyanobacterial cytosol, the
regulatory metalloprotein Synechococcus PCC7942 SmtB func-
tions in response to ZnII coordination but not CoII, even
though in vitro studies have shown that ZnII and CoII both
bind to the same tetrahedral allosteric site.[54] In contrast, the
NiII and CoII responsive metalloprotein NmtR from Mycobacteri-
um tuberculosis regulating the nmt operator, contains an allo-
steric metal-binding site on helix a5 of the winged helix–turn–
helix motif, similarly to SmtB, but which offers two additional
ligands for potential metal-ion coordination in an octahedral
fashion. Coordination of these two additional ligands would re-
quire reorganisation, leading to a structural transition which in
turn inhibits DNA binding. ZnII binds to NmtR with a greater af-
finity than CoII, but in a tetradentate rather that an hexaden-
tate fashion, and is therefore unable to regulate DNA bind-
ing.[3,55] These examples illustrate that metal-ion allosteric regu-
lation can be highly dependent on preferred metal-ion coordi-
nation geometry and how that might alter protein structure,
rather than metal-ion affinity. Therefore, our examples above
need to be considered not in terms of enhanced metal-ion af-
finity and resulting DNA affinity, but rather in combination
with preferred coordination geometry and resulting DNA
affinity.
DNA sequence selectivity
To gain further insight into the sequence-selective DNA bind-
ing of our three artificial peptide dimers, (GCN4bd)2, bipy-
(GCN4bd)2, and terpy(GCN4bd)2, similar CD experiments were
carried out with DNA containing either the AP1 or half-CRE
site. AP1 lacks a central G–C nucleobase pair, in contrast to the
palindromic CRE site, and is in fact the natural binding site of
GCN4.[56,57] However, much of the artificially dimerised GCN4 lit-
erature has focused on CRE DNA,[12a,15,58] which has been
shown to better accommodate the bulk resulting from artificial
dimerisation linkers.[14c] In contrast, half-CRE contains half of
the palindromic repeat of CRE, and therefore represents the
docking domain for only one of the two peptide a-helices of
GCN4. Previous studies have demonstrated that homodimeric
peptides based on GCN4 which contain both the conserved
basic and zipper domains, display similar binding affinities for
CRE, AP1 and half-CRE DNA.[59]
A slight increase in the helicity of (GCN4bd)2 and bipy-
(GCN4bd)2 is observed in their CD spectra recorded in the
presence of either AP1 or half-CRE DNA, similar to that in the
presence of CRE DNA (but in the absence of metal ions), and
to previous reports (Figure 7A and B).[14c] However, almost no
change is observed for terpy(GCN4bd)2 (Figure 7C). As expect-
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ed the addition of either CuCl2 or ZnCl2 does not alter the CD
spectrum of (GCN4bd)2 which lacks a metal chelating linker
unit. More intriguingly, however, is that the addition of metal
ions does not significantly alter the CD spectra of bipy-
(GCN4bd)2 in the presence of either AP1 or half-CRE DNA, de-
spite being sensitive to the presence of these metal ions in the
presence of CRE DNA. In contrast, the helicity of terpy-
(GCN4bd)2 in the presence of half-CRE and AP1, is very sensi-
tive to the presence of metal ions. For both half-CRE and AP1
DNA the addition of ZnII is consistent with a more a-helical
peptide (half-CRE V222 6.6103!11.0103; AP1 V222
6.3103!11.3103 degdmol1 cm2 per residue), of similar
a-helicity as both (GCN4bd)2 and the bipy(GCN4bd)2 ana-
logue. However, the addition of CuII is accompanied by a very
significant increase in the a-helical signal at 222 nm (half-CRE
V222 6.1103!16.9103; AP1 V222 4.9103!22.6
103 degdmol1 cm2 per residue), in much the same fashion as
was previously observed in the presence of CRE DNA (Figures 5
and 7), but is greater in the presence of DNA containing the
AP1 target site.
These results are in extremely good agreement with our
original design. We proposed that 5,5’-disubstituted bipyridine,
in both the cisoid and transoid conformation, and the cisoid
conformation of 6,6’-disubstituted terpyridine, would separate
peptide substituents by an appropriate distance for binding to
the CRE DNA target site. The distance between peptides on
binding to AP1 is shorter than when bound to CRE (Figure 3).
Therefore, we proposed that the analogous binding to AP1
DNA would only be well satisfied by the cisoid conformation of
the 6,6’-disubstituted terpyridine peptide dimer, terpy-
(GCN4bd)2, and that this conformation would be promoted on
metal-ion coordination. Consistent with data for binding to
CRE, binding to AP1 DNA is significantly enhanced on coordi-
nating CuII, for which the terpyridine linker displays a higher af-
finity (compared to ZnII). We have, therefore, managed to alter
the metal-ion induced sequence selectivity, by changing the
nature of a non-native regulation site, as opposed to the DNA
binding peptide sequence.
Conclusions
Herein we report for the first time the design of artificial DNA
binding peptide dimers which contain a non-native metal de-
pendent switching domain as the linker unit. The polypyridine
linker units have been selected such that metal-ion coordina-
tion will promote the cisoid conformation, which could trigger
the alignment of peptide moieties capable of sequence-selec-
tive binding to DNA. Three peptide dimers; bipy(GCN4bd)2,
which contains an allosteric ineffective 2,2’-bipyridine unit,
terpy(GCN4bd)2, which contains the allosteric effective
2,2’:6’,2’’-terpyridine unit, and (GCN4bd)2, which contains a di-
sulfide bond, which is insensitive to the presence of metal
ions, are reported. CD studies are consistent with all three con-
jugates folding into a-helices in the presence of DNA contain-
ing the CRE target site, and that this is greatly enhanced on
coordinating either CuII or ZnII for those dimers containing
Figure 7. CD spectra of 5 mm solutions of half-CRE (A, B and C) and AP1 (D, E and F) DNA and (GCN4bd)2 oxidised dimer (A and D), bipy(GCN4bd)2 (B and E)
and terpy(GCN4bd)2 (C and F) in 10 mm phosphate buffer pH 7.4, in the absence (g) and presence of 2 equivalents of either CuCl2 (a) or ZnCl2 (c).
Reversibility was monitored by addition of 10 equivalents of EDTA (c).
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polypyridine linker units, bipy(GCN4bd)2 and terpy(GCN4bd)2.
Metal-ion coordination and peptide realignment to promote
DNA binding is fully reversible upon addition of excess EDTA.
Notably a higher metal-ion affinity was not found to correlate
with enhanced binding to CRE DNA, due to apparent coordina-
tion geometry requirements for allostery. Complementary stud-
ies performed in the presence of AP1 DNA, which differs from
CRE in a single nucleobase pair, displays the most significant
CD change, for metallated terpy(GCN4bd)2 (greatest for Cu
II),
which is consistent with a cisoid-terpyridine conformation
which positions the two peptide moieties at an optimal dis-
tance for binding to the smaller AP1 DNA target site. In con-
trast, similar metal addition did not result in significant
changes in the CD profile of bipy(GCN4bd)2 recorded in the
presence of AP1, where the interpeptide distance is too large
for optimal binding to AP1 DNA.
Here we illustrate that switching units can be introduced
into artificial DNA binding proteins, that can be regulated by
coordinating metal ions, triggering a conformational change
promoting sequence-selective DNA binding. Importantly the
linker unit can be carefully designed so as to achieve discrimi-
nation between two very similar DNA target sites, which differ
only in a single nucleobase pair. We propose that these metal
dependent switches could be engineered into various designer
proteins to control biomolecular recognition events which rely
on a high level of specificity. Ultimately we envision that bio-
molecules containing these switches could find applications in
the future as tools in biotechnology. Moreover, polypyridine li-
gands are routinely used as part of the inorganic chemist’s
toolbox, and can be found in a large number of complexes de-
veloped for biological applications, including luminescent
probes, anticancer agents, and as catalysts. Therefore, the li-
gands reported here could offer opportunities to couple the
attractive properties of these complexes with a high degree of
control over biomolecular recognition.
Experimental Section
Materials, methods, and synthetic procedures are described in the
Supporting Information.
UV–visible spectroscopy
UV–visible spectra were recorded in a 1 cm pathlength quartz cuv-
ette at 298 K on a Shimadzu 1800 spectrometer. For a metal-ion ti-
tration of the peptide conjugates, aliquots of aqueous 0.3 mm
stock solutions of CuCl2 or ZnCl2, were titrated into 600 mL of a 5(
0.6) mm solution of polypyridyl–peptide dimer conjugate (5.28
(bipyZn), 5.24 (bipyCu), 4.51 (terpyZn) and 4.44 mm (terpyCu)) in 20 mm
potassium phosphate buffer pH 7.4, containing 5 mm of double
stranded oligonucleotide (either CRE or NS), if present. Spectra
were recorded after 3 min equilibration. When the apparent CuII
binding constant was too high to be accurately estimated, glycine
was added as a competitor ligand; 20 mm glycine and 100 mM
phosphate buffer were present for the titration of bipy(GCN4bd)2
in the absence of DNA, 10 mm glycine and 50 mM phosphate
buffer in the presence of both CRE and NS DNA, and 0.2 mm gly-
cine for the titration of terpy(GCN4bd)2 in the presence of CRE
DNA. Nonlinear fitting was performed with Kaleidagraph software
version 4.0 and Kapp values were calculated as reported
previously.[27]
For the continuous variation method experiment, solutions of vary-
ing ratio of bipy(GCN4bd)2/terpy(GCN4bd)2 and CuCl2/ZnCl2 were
prepared from 120 mm stock solutions, so that the total concentra-
tion of Cp+Cm was 10 mm (where Cp and Cm, correspond to the
concentration of the peptide dimer conjugate and metal ion, re-
spectively). UV–visible spectra were recorded and the absorbance
at lmax, for the metal complexes p!p* transition, was plotted
versus the fraction of ligand. Due to a contribution at this wave-
length from the free ligand (bipy(GCN4bd)2 and terpy(GCN4bd)2),
the absorbance values were corrected to account for this.[60] The
fraction of peptide conjugates, c bipy(GCN4bd)2 and c terpy-
(GCN4bd)2, are defined as the ratio Cp/(Cp+Cm).
Circular dichroism spectroscopy
CD spectra were recorded in a 1 mm pathlength quartz cuvette at
298 K on a Jasco J-715 spectropolarimeter. The observed elliptici-
ties in millidegrees were converted into residual molar ellipticity,
FRME, reported in units of degdmol
1 cm2 per residue. For CD spec-
tra of peptide conjugates in the presence and absence of DNA,
a 300 mL blank solution containing 10 mm phosphate buffer pH 7.4
and 5 mm duplex DNA (if present) was recorded. Peptide dimer or
peptide dimer conjugate solution (7.5 mL of a 200 mm solution) was
added, and the data were collected after 15 min equilibration. Two
equivalents of CuCl2 or ZnCl2 (2 mL, 1.5 mm) was added and the so-
lution was allowed to equilibrate for 15 min prior to recording the
spectra. Ten equivalents of EDTA per metal ion (3 mL, 10 mm) were
added and the CD spectra were recorded, in order to investigate
reversibility. Spectra are an average of 20 scans recorded between
185 and 400 nm, at 500 nmmin1 (0.5 nm pitch). Difference spectra
were obtained by subtracting the CD spectrum of DNA alone
(blank), from that of a mixture containing both peptide and DNA,
in order to observe the CD contribution from the peptide compo-
nent only.
Metal titrations of peptide/CRE DNA complexes were performed at
a higher concentration (10 mm bipy(GCN4bd)2/terpy(GCN4bd)2,
10 mm DNA). To a 1 mm pathlength cuvette, 60 mL of a 50 mm solu-
tion of CRE DNA, 30 mL of 100 mm phosphate buffer pH 7.4 and
195 mL deionised water, were successively added. A blank spectrum
was recorded, and 15 mL of bipy(GCN4bd)2 or terpy(GCN4bd)2 so-
lution (200 mm) was added. Samples were allowed 15 min equili-
bration prior to recording the spectra. Aliquots of aqueous stock
solutions of CuCl2 or ZnCl2 (0.3 mm) were then titrated into the so-
lution containing 10 mm of the peptide–CRE DNA complex, and the
CD were recorded after 7 min equilibration. Spectra are an average
of eight scans recorded between 190 and 300 nm at 200 nmmin1
(0.5 nm pitch). The DNA blank was subtracted as previously de-
scribed, and the molar ellipticity values were corrected to account
for dilution.
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